- Super User
- Progress
- Read Time: 1 min
- Hits: 0
Our Site was invited to participate in a new clinical trial of a new medicine for the biological therapy of severe eosinophilic bronchial asthma, conducted by the pharmaceutical company GSK.
Our Site was invited to participate in a new clinical trial of a new medicine for the biological therapy of severe eosinophilic bronchial asthma, conducted by the pharmaceutical company GSK.
The staff of the Site took an active part in the 16th National Congress of Therapists. The Congress program covered the widest possible range of issues of diagnosis, prevention and treatment of internal diseases. We thank the organizers for the invitation!
We continue to participate in protocols for the treatment of inflammatory bowel diseases: a portfolio of new studies on Crohn's disease and ulcerative colitis.
Participation in a clinical study of a new biological therapy for the treatment of Covid-19 infection in children is proposed.